The Current Ratio as of December 2025 (TTM) for Greenyn Biotechnology Co., Ltd (6846.TWO) is 6.47

According to Greenyn Biotechnology Co., Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 6.47. This represents a change of 29.73% compared to the average of 4.99 of the last 4 quarters.

Greenyn Biotechnology Co., Ltd (6846.TWO) Historical Current Ratio (quarterly & annually)

How has 6846.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Greenyn Biotechnology Co., Ltd over the last ten years is 3.10. The current 6.47 Current Ratio has changed 20.77% with respect to the historical average. Over the past ten years (40 quarters), 6846.TWO's Current Ratio was at its highest in in the June 2025 quarter at 6.47. The Current Ratio was at its lowest in in the September 2021 quarter at 0.

Greenyn Biotechnology Co., Ltd (6846.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Greenyn Biotechnology Co., Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Greenyn Biotechnology Co., Ltd (6846.TWO) Average Current Ratio

How has 6846.TWO Current Ratio performed in the past?

The current Current Ratio of Greenyn Biotechnology Co., Ltd (6846.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Greenyn Biotechnology Co., Ltd (6846.TWO) Current Ratio vs. Peers

How is 6846.TWO’s Current Ratio compared to its peers?

Greenyn Biotechnology Co., Ltd’s Current Ratio is less than Advagene Biopharma Co., Ltd. (30.83), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.82), greater than Genomics BioSci & Tech. Co.,Ltd. (1.35), greater than Sunny Pharmtech Inc. (1.30), greater than Winston Medical Supply Co., Ltd. (1.60), greater than Crystalvue Medical Corporation (2.56), greater than TSH Biopharm Corporation Limited (4.94), less than Hcmed (11.14), greater than Meribank Biotech Co., Ltd (1.58), greater than Chi Sheng Pharma & Biotech Co., Ltd (1.84),

Build a custom stock screener for Greenyn Biotechnology Co., Ltd (6846.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenyn Biotechnology Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Greenyn Biotechnology Co., Ltd (6846.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Greenyn Biotechnology Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.